SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Ed Ajootian who wrote (7311)1/22/2004 11:47:34 PM
From: rkrw  Read Replies (1) | Respond to of 10280
 
<<Whatever happened to Oxybutynin, the incontinence drug? I thought they had already taken that pretty far, surprised to see it off the list.>>

q&a it was mentioned. Sounds like it may have formulation issues and has been tabled. Always thought it could be a good outlicense to JNJ, but probably far too late for that and maybe there were formulation issues all along that would have precluded it.